Evidence map›Paper›PMID 41035679›Full record

ArticleiScience2025

Mao Hagihara, Makoto Yamashita, Tadashi Ariyoshi, Ayaka Minemura, Chika Yoshida, Seiya Higashi, Kentaro Oka, Motomichi Takahashi, Akinobu Ota, Akihiro Maenaka and 8 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mao HagiharaDepartment of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute 480-1195, Japan.
Makoto YamashitaDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Tadashi AriyoshiDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Ayaka MinemuraR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
Chika YoshidaR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
Seiya HigashiR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
Kentaro OkaR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
Motomichi TakahashiR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
Akinobu OtaDepartment of Pharmacy, College of Pharmacy Kinjo Gakuin University, Nagoya 463-8521, Japan.
Akihiro MaenakaDepartments of Kidney Disease and Transplant Immunology, Aichi Medical University, Nagakute 480-1195, Japan.
Kenta IwasakiDepartments of Kidney Disease and Transplant Immunology, Aichi Medical University, Nagakute 480-1195, Japan.
Jun HiraiDepartment of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute 480-1195, Japan.
Yuichi ShibataDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Takumi UmemuraDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Takeshi MoriDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Hideo KatoDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Nobuhiro AsaiDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
Hiroshige MikamoDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that orally administered

Indexed as

Cell biologyMicrobiology

Identifiers

PMID41035679
PMCPMC12483594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.